News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News TCT 2023 Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots Caitlin E. Cox November 03, 2023
News Conference News TCT 2022 Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning Shelley Wood September 19, 2022
News Conference News STS 2020 Age-Old Debate: When Does the Senior Surgeon Put the Scalpel Away? Yael L. Maxwell February 06, 2020
News Conference News STS 2019 No ‘July Effect’ Observed in Cardiac Surgery Yael L. Maxwell February 05, 2019
News Conference News STS 2019 TAVR More Prevalent in Highly Competitive Hospital Markets Yael L. Maxwell February 04, 2019
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News TCT 2017 Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock Yael L. Maxwell November 09, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016